ALX Oncology Inc. (ALXO)
NASDAQ: ALXO
· Real-Time Price · USD
0.49
-0.04 (-7.83%)
At close: Jun 17, 2025, 3:59 PM
-7.83% (1D)
| Bid | 0.47 |
| Market Cap | 26.45M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -130.02M |
| EPS (ttm) | -2.45 |
| PE Ratio (ttm) | -0.2 |
| Forward PE | -0.4 |
| Analyst | Buy |
| Ask | 0.52 |
| Volume | 279,567 |
| Avg. Volume (20D) | 482,474 |
| Open | 0.53 |
| Previous Close | 0.53 |
| Day's Range | 0.48 - 0.55 |
| 52-Week Range | 0.41 - 8.78 |
| Beta | 1.16 |
About ALXO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALXO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALXO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-19.08%
ALX Oncology Holdings shares are trading lower. Th...
Unlock content with
Pro Subscription
3 months ago
+25.96%
ALX Oncology Holdings shares are trading higher after Piper Sandler and Jefferies upgraded their respective price targets on the stock.
